Torque Therapeutics Stock

torquetx.comHealthcare / BioTech & PharmaFounded: 2015Funding to Date: $84.27MM

Developer of an online platform intended to provide immunotherapy services. The company is focused on the specific modulation of immune cell subsets based on novel platform technologies to address intractable cancers, particularly solid tumors, enabling doctors to get new cell therapy cures for cancer.

Register To Buy and Sell Shares

For more details on financing and valuation for Torque Therapeutics, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

OverviewFinancingsValuation

Enterprise Value

Powered by Forge Data

Access Torque Therapeutics’ valuation and stock price.

View secondary pricing information, VWAP and distribution waterfall. And seek potentially outsized returns with same day private market data for private companies like Torque Therapeutics.

Become part of the Secondary Marketplace, catering to both individual and institutional investors.

Register

Animation displayed is not current and securities are shown for illustrative purposes only.

Team

Management Team

Bart Henderson
Co-Founder, President & Board Member
Thomas Andresen Ph.D
Co-Founder and Chief Scientific Officer
Stephen Hodi MD
Scientific Advisory Board Member
Doug Cole MD
Chairman
John Cox
Chief Executive Officer & Board Member
Douglas Jones
Director
Darrell Irvine Ph.D
Co-Founder
Sok Cheng Soh
Chief Financial Officer
Jennifer Camacho JD
Chief Legal Officer
Becker Hewes MD
Chief Medical Officer

Board Members

Doug Cole MD
John Dineen
Douglas Lauffenburger Ph.D
John Cox
Bart Henderson
John Hohneker MD

Torque Therapeutics’ stock FAQs

plusminus

Can you buy Torque Therapeutics’ stock?

Torque Therapeutics is not publicly traded on NYSE or NASDAQ in the U.S. To buy Torque Therapeutics’ stock you need to be an accredited investor. Learn more about how to invest in the private market or register today to get started.
plusminus

Can you sell Torque Therapeutics’ stock?

Yes, you can sell stock of a private company like Torque Therapeutics. Forge can help you sell your Torque Therapeutics stock in a way that works for you and the company. So if you are seeking liquidity, register with us today to get started.
plusminus

What is Torque Therapeutics’ stock price?

Torque Therapeutics is a privately held company and therefore does not have a public stock price. However, you may access Torque Therapeutics’ private market stock price with Forge Data.
plusminus

What is Torque Therapeutics’ stock ticker symbol?

Torque Therapeutics does not have an official ticker symbol because this company is not currently publicly traded.
plusminus

Can institutional investors buy and sell private market stocks?

Yes. As one of the largest trading platform for the private market, Forge helps institutional investors seek liquidity as they buy and sell private stock for their portfolios or their clients. Our private market specialists have decades of experience working with institutional firms. Learn more or register today to get started.

News Highlights

Torque Therapeutics Announces the Appointment of John Cox as Chief Executive Officer

Torque Therapeutics, a clinical stage, product-platform company developing proprietary, first-in-class Deep Primed™ adoptive cell transfer therapeutic

Xconomy: With $25M, Torque Aims for a More Targeted Cell Therapy for Cancer

Genetic engineering a patient’s own immune cells to make them better cancer fighters is the latest tool in oncology, following FDA approvals of two such
Updated on: Jun 24, 2024

PLEASE READ THESE IMPORTANT LEGAL NOTICES & DISCLOSURES

Public news articles listed on this page have been curated by Forge based on several factors including, but not limited to, product updates, changes in organization structure, funding rounds, third-party valuations, and key personnel changes. Changes to this list of articles can be made at any time without notice and should not be relied upon for investment purposes. Forge does not verify the accuracy of the information contained in public news articles.